key: cord-0847690-llt22s2j
authors: Baimukhamedov, Chokan; Makhmudov, Shosaid; Botabekova, Aliya
title: Seropositive rheumatoid arthritis after vaccination against SARS‐CoV‐2 infection
date: 2021-09-29
journal: Int J Rheum Dis
DOI: 10.1111/1756-185x.14220
sha: 7ea13ada434440611bf50cce8f54a32e68eff267
doc_id: 847690
cord_uid: llt22s2j

nan

increasing of RF and ACPA is significant. We described the rapid growth of ACPA within a month from normal values (18 mg/L) to high values (104 U/mL) 8 in a case of RA that developed after SARS-CoV-2. It is likely that in this case, the vaccination might have been a trigger factor for the rapid onset of RA. It would be appropriate to conduct a genetic study of the patient, as French researchers did; 9 however, similar to other post-vaccine case reports, the causal correlation with RA was not formally established. Nonetheless, we assume that vaccination and SARS-CoV-2 might be trigger factors for

Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection

Flare of rheumatoid arthritis after COVID-19 vaccination

Adult-onset Still's disease after mRNA COVID-19 vaccine

Reactive arthritis after COVID-19 vaccination

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous primeboost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age

Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative

Arthritis after SARS-CoV-2 infection

First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection